Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Celecoxib Intervention in Acute Pancreatitis (MSAP/SAP Prevention)
ChiCTR2500108717Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute pancreatitis (AP) comparing Celecoxib group with Placebo group (2 arms). Primary endpoint: Incidence of organ failure. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
celecoxib
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on ChiCTR2500108717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108717.